Vallota E H, Müller-Eberhard H J
J Exp Med. 1973 May 1;137(5):1109-23. doi: 10.1084/jem.137.5.1109.
Two biologically and chemically distinct anaphylatoxins (ATs) could be generated in whole human serum after removal of the AT inactivator (AI) by immune-absorption or after inhibition of AI with 1 M epsilon-aminocaproic acid (EACA). Both human ATs could be generated by treatment of serum with antigen-antibody complexes, which activate the classical complement pathway, and with inulin or yeast, both of which trigger the alternate pathway. The ATs were isolated from serum in active form and characterized as C3a and C5a. Although human C3a had been characterized previously, C5a had not. The molecular weight of human C5a AT was 17,500; its electrophoretic mobility at pH 8.5 was -1.7 x 10(-5) cm(2) V(-1) s(-1). The minimal effective concentration in vitro was 7.5 x 10(-10) M. The minimal effective doses of human C5a in producing a wheal and erythema in the human skin was 1 x 10(-15) mol. The results strongly suggest a biological function for both ATs and indicate that the expression of their activity is controlled by the AI of normal blood plasma.
通过免疫吸附去除过敏毒素灭活剂(AI)后,或用1Mε-氨基己酸(EACA)抑制AI后,在全人血清中可产生两种生物学和化学性质不同的过敏毒素(ATs)。两种人源ATs均可通过用激活经典补体途径的抗原-抗体复合物以及菊粉或酵母处理血清产生,菊粉和酵母均可触发替代途径。这些ATs以活性形式从血清中分离出来,并被鉴定为C3a和C5a。尽管人C3a先前已有特征描述,但C5a还没有。人C5a过敏毒素的分子量为17,500;其在pH 8.5时的电泳迁移率为-1.7 x 10(-5) cm(2) V(-1) s(-1)。体外最小有效浓度为7.5 x 10(-10) M。人C5a在人皮肤中产生风团和红斑的最小有效剂量为1 x 10(-15) mol。结果强烈提示两种ATs均具有生物学功能,并表明它们活性的表达受正常血浆AI的控制。